文献速递肝病

系统综述与Meta分析:肝移植后原发性硬化性胆管炎复发的危险因素

Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.
PubMed 文献 · Aliment Pharmacol Ther · 2019-02-10

该研究检索Pubmed、Embase、Web of Science和Cochrane图书馆至2018年3月的文献,纳入21项回顾性队列研究,其中14项进入Meta分析,最终队列包含2159例患者(年龄范围31-49岁,68.8%男性),17.7%发生复发性原发性硬化性胆管炎(rPSC)。分析发现移植前结肠切除术、移植前胆管癌、炎症性肠病、供者年龄、MELD评分和急性细胞性排斥反应与rPSC风险相关,移植前结肠切除术可降低rPSC风险。

要点

  • 移植前结肠切除术与rPSC风险降低相关,HR 0.65(95%CI:0.42-0.99)。
  • 移植前胆管癌、炎症性肠病和急性细胞性排斥反应与rPSC风险升高相关。
  • 供者年龄每增加十年及MELD评分每增加一点与rPSC风险升高相关。

核心结论

  • 研究识别了多个rPSC的危险因素。
  • 移植前结肠切除术可降低rPSC风险。

研究设计与样本

  • 系统综述与Meta分析,检索Pubmed、Embase、Web of Science和Cochrane图书馆截至2018年3月发表的文章。
  • 21项回顾性队列研究符合纳入标准,其中14项纳入Meta分析。
  • 最终队列包含2159例患者,年龄范围31-49岁,68.8%为男性,17.7%发生rPSC。
  • 使用随机效应Meta分析,以风险比(HR)作为效应量。
  • 研究质量采用纽卡斯尔-渥太华量表评估,统计分析使用Cochrane Review Manager进行。

主要发现

  • 移植前结肠切除术与rPSC风险相关,HR 0.65(95%CI:0.42-0.99)。
  • 移植前胆管癌与rPSC风险相关,HR 2.42(95%CI:1.20-4.86)。
  • 炎症性肠病与rPSC风险相关,HR 1.73(95%CI:1.17-2.54)。
  • 供者年龄每增加十年与rPSC风险相关,HR 1.24(95%CI:1.0-1.45)。
  • MELD评分每增加一点与rPSC风险相关,HR 1.05(95%CI:1.02-1.08);急性细胞性排斥反应与rPSC风险相关,HR 1.94(95%CI:1.32-2.83)。

局限性

  • 纳入的研究均为回顾性队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After liver transplantation primary sclerosing cholangitis (PSC), the condition returns in the transplanted liver in a subset of patients (recurrent primary sclerosing cholangitis, rPSC). AIM: To define risk factors for rPSC. METHODS: We searched Pubmed, Embase, Web of Science, and Cochrane library for articles published until March 2018. Studies addressing risk factors for developing rPSC were eligible for inclusion. A random effects meta-analysis was conducted using hazard ratios (HR) as effect measure. Study quality was evaluated with the Newcastle Ottawa scale. Statistical analysis was performed using Cochrane Review Manager. RESULTS: The electronic database search yielded 449 results. Twenty-one retrospective cohort studies met the inclusion criteria for the review; 14 were included in the meta-analysis. The final cohort included 2159 patients (age range 31-49 years, 68.8% male), of whom 17.7% developed rPSC. Colectomy before liver transplantation, HR 0.65 (95% CI: 0.42-0.99), cholangiocarcinoma before liver transplantation, HR 2.42 (95% CI: 1.20-4.86), inflammatory bowel disease, HR 1.73 (95% CI: 1.17-2.54), donor age, HR 1.24 (95% CI 1.0-1.45) per ten years, MELD score, HR 1.05 (95% CI: 1.02-1.08) per point and acute cellular rejection, HR of 1.94 (95% CI: 1.32-2.83) were associated with the risk of rPSC. CONCLUSIONS: Multiple risk factors for rPSC were identified. Colectomy before liver transplantation reduced the risk of rPSC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Steenstraten IC, Sebib Korkmaz K, Trivedi PJ, et al. Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation. Aliment Pharmacol Ther. 2019. PMID: 30740723. doi:10.1111/apt.15148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。